India’s First Alzheimer’s Disease-Modifying Therapy Is Now Available — What It Means for Patients and Hospitals

For decades, treating Alzheimer’s disease in India meant managing symptoms. Medications like rivastigmine and donepezil could slow cognitive decline for a period, but nothing available in the Indian market could actually target the disease process itself — the accumulating amyloid